Backing the best Health and Biomedical ventures of tomorrow

About Us



To build innovative healthcare and biomedical companies that result in impactful patient outcomes.

Why Coronet?

US Market Entry

The U.S. accounts for nearly 50% of global healthcare expenditures. We offer you a landing pad in the U.S. through our affiliation with Cedars-Sinai, as well as the chance to launch your solutions in other hospitals and clinics in the Cedars-Sinai health system. The timing could not be better for you to make your mark on the U.S. healthcare industry.

Clinical Ecosystem

You will gain access to relevant clinical experts from Cedars-Sinai Medical Center who can help you validate your solutions in a clinical setting and champion your cause to stakeholders in our ecosystem. Running a clinical trial across our sites becomes easier once you become part of Cedars-Sinai’s clinical ecosystem and understand its requirements.

Startup Support Ecosystem

Cedars-Sinai launched its Accelerator program in 2017. Since then, over 80 companies from around the world have experienced our three-month bootcamp. It has helped both Cedars-Sinai and our companies make tangible impacts on patient care. As a Coronet Ventures investee, you will have access to the Cedars-Sinai Accelerator’s network of alumni startups who can help you on your journey. At the same time, our internal and external mentors will be there to guide you. In addition, Cedars-Sinai’s technology transfer office can support you in protecting your intellectual property, filing your FDA submissions, and licensing and commercializing your technology.


Nirdesh Gupta, PhD

Chief Executive Officer

Colin Tan

Investment Director


David Wrigley

Executive Vice President & Chief Financial Officer
CEdars-Sinai Health System

James Laur

Cedars Sinai Intellectual Property Company

Edward Prunchunas

Board Member
Cedars Sinai Intellectual property company

Investment strategy

Investment Stage

Seed to Series A

Cheque size

US$500K - $6M